Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Abroad (travel likely)Recruiting

Conditions

NAFLD · Inflammatory Bowel Diseases · Steatosis · Fibrosis, Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Saint Pierre, Brussels, Belgium
Contact: Study coordinator (Jennifer Aoun, Medical doctor) · jennifer.aoun@stpierre-bru.be · +32 25353296
Contact: Study coordinator (Vinciane Muls, Medical doctor) · vinciane.muls@stpierre-bru.be · +32 25354455
Contact: Principal Investigator (Jennifer Aoun, Medical doctor)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis · Fibrosis

Abroad (travel likely)Recruiting

Beijing, China

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD

Abroad (travel likely)RecruitingPHASE2

Richmond, United States

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

Liver Steatoses · Liver Metastasis Colon Cancer · NAFLD

Abroad (travel likely)Recruiting

London, Canada

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Nonalcoholic Steatohepatitis (NASH) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Abroad (travel likely)RecruitingPHASE1

Columbia, United States